AC Immune (ACIU) Net Debt Issuances and Repayments (2022 - 2025)
AC Immune's (ACIU) quarterly Net Debt Issuances and Repayments came in at -$317527.8 in Q3 2025, down 59.02% year-on-year from -$774837.0 in Q3 2024, and down 6.43% on a QoQ basis from -$298348.9 in Q2 2025.
AC Immune (ACIU) Net Debt Issuances and Repayments (2022 - 2025) Analysis & Trends
AC Immune (ACIU) has 4 years of Net Debt Issuances and Repayments data on file, last reported at -$317527.8 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Debt Issuance (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | AC Immune | 225.68 Mn | 225.68 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -317,527.82 |
| Sep 30, 2025 | -317,527.82 |
| Jun 30, 2025 | -298,348.89 |
| Jun 30, 2025 | -298,348.89 |
| Mar 31, 2025 | -286,960.64 |
| Mar 31, 2025 | -286,960.64 |
| Sep 30, 2024 | -199,677.85 |
| Sep 30, 2024 | -199,677.85 |
| Jun 30, 2024 | -68,559.20 |
| Jun 30, 2024 | -68,559.20 |
| Mar 31, 2024 | -788,229.43 |
| Mar 31, 2024 | -788,229.43 |
| Mar 31, 2023 | -152,443.92 |
| Mar 31, 2023 | -152,443.92 |
| Mar 31, 2022 | -991,852.47 |
| Mar 31, 2022 | -991,852.47 |